Adults diagnosed with narcolepsy type 2 and idiopathic hypersomnia (IH)

You may qualify and be compensated up to $2,750 for participating in this study if you meet the following criteria:

• Males and females 18- 65 years old
• Diagnosed with narcolepsy type 2 (without cataplexy) or with idiopathic hypersomnia (IH)
• BMI between 18 and 45 (use the BMI calculator below)
• Non-smokers
• Additional criteria apply

Check-in dates: Will be set up according to the participants' availability

To participate, contact Mrs. Luz Stevens at 973-388-8448 or luz.stevens@biotrial.com

Refer a friend: Earn up to $500 if your friend is eligible and participates in this study.

Study objective: Provide preliminary data regarding initial clinical proof of concept, tolerability, and safety of the investigational study drug ALKS2680 in the narcolepsy type 2 and idiopathic hypersomnia (IH) patient populations.

What is narcolepsy? Narcolepsy is a sleep disorder that makes people very drowsy during the day. They find it hard to stay awake for long periods, fall asleep suddenly, and may have hallucinations. Idiopathic hypersomnia (IH) is a sleep disorder in which a person is excessively sleepy (hypersomnia) during the day and has great difficulty being awakened from sleep.